ClinicalTrials.gg
Sign In

Colonic Neoplasms clinical trials

The registry lists 2,457 studies for Colonic Neoplasms across more than 10 countries. 458 are recruiting or about to start. 1,347 of them are mainly about Colonic Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its narrower condition Sigmoid Neoplasms too: 2,474 studies, 461 open.

ClinicalTrials.gov finds 8,359 studies for Colonic Neoplasms. How that becomes 2,458 here

This page counts the studies the registry files under Colonic Neoplasms, and those it files under no condition that list Colonic Neoplasmsthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 8,359Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −17Filed under a narrower condition, counted on its own pageSigmoid Neoplasms 17
  3. −65List Colonic Neoplasms as a condition, but the registry did not file them under itMost often written as “Liver Metastasis Colon Cancer” (31), “Colon Cancer Screening” (6), and “Colon Cancer Liver Metastasis” (5). The registry filed them under other conditions only, most often Colorectal Neoplasms (31) and Liver Neoplasms (8).
  4. −5,819Match it another way150 name it in the title, 25 in a keyword, and 5,644 by a synonym or other text the search reads.
  5. 2,458The count on this page76 of them list Colonic Neoplasms in their own words; the registry filed them under no condition.

Get an email when these change. Save the Colonic Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
1,218
Status unknown
334
Recruiting
326
Terminated
221
Active, not recruiting
134
Not yet recruiting
115

Phase

Phase 2
619
Phase 1
438
Phase 3
242
Phase 4
42
Early Phase 1
26

Where

United States
1,122
France
213
China
211
Italy
135
Spain
121
Canada
115

Who runs them

National Cancer Institute (NCI) (114) · Memorial Sloan Kettering Cancer Center (53) · Alliance for Clinical Trials in Oncology (40) · M.D. Anderson Cancer Center (33) · City of Hope Medical Center (30) · Fudan University (19) · GERCOR - Multidisciplinary Oncology Cooperative Group (18) · Case Comprehensive Cancer Center (18)

What is being tested here

Drugs under test in Colonic Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Cetuximab61257
Bevacizumab51371
Tislelizumab528
Oxaliplatin428108
Irinotecan42089
Pembrolizumab417
Iparomlimab/Tuvonralimab414
Dostarlimab414
Capecitabine31152
Nivolumab3215

Drug classes tested here Immune checkpoint inhibitors 43 open · Antimetabolites 7 open · Tyrosine kinase inhibitors (TKIs) 6 open · Angiogenesis inhibitors 5 open · Alkylating agents 2 open

Coming up

56phase 3 studies under way
150studies finish main data collection within a year7 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 326 Colonic Neoplasms studies recruiting now, 203 (62%) set no upper age limit and 71 (22%) stop at 75 or younger. 19 (6%) take children under 18. 3 (1%) are for women only and 0 (0%) for men only; 34 (10%) take healthy volunteers.

Recruiting studies that take each age, of 326
AgeWomenMen
1013 (4%)13 (4%)
18290 (89%)288 (88%)
30304 (93%)302 (93%)
40308 (94%)306 (94%)
50313 (96%)311 (95%)
65314 (96%)312 (96%)
75307 (94%)305 (94%)
85237 (73%)237 (73%)

Across all 2,457 studies, recruiting or not: 17% stop at 75 or younger and 3% at 65; 8% take children; 1% are for women only and <1% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Colonic Neoplasms studies take

Of 135 phase 2 interventional studies under Colonic Neoplasms, half reached primary completion within 43 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 148 mo32–69 · 116 studies49 mo30–64 · 51 studies46 mo32–69 · 65 studies
Phase 1/265 mo41–93 · 60 studies——
Phase 243 mo30–66 · 135 studies—43 mo29–66 · 122 studies
Phase 355 mo37–119 · 72 studies—87 mo39–123 · 55 studies
Phase 429 mo20–105 · 16 studies——
Interventional, no phase30 mo16–51 · 404 studies—31 mo17–55 · 382 studies
Observational50 mo24–116 · 224 studies—54 mo24–116 · 186 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting4

Results posted2

Stopped1

Newly registered10

Show 5 more

Studies

Recruiting first, then most recently updated. Showing 50 of 2,457. Browse all 2,457 → or search them.